secwatch.observer — SEC 8-K summary
======================================

Issuer:     AbbVie Inc. (ABBV)
CIK:        0001551152
Form:       8-K
Filed at:   2026-03-04T23:59:59+00:00
Accession:  0001104659-26-023534
Event type: debt
Sentiment:  neutral
Materiality: 0.60
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

AbbVie closes $7.75B debt offering across seven tranches (2028-2066)
--------------------------------------------------------------------

- Completed public offering of $750M floating rate notes due 2028 and $7B in fixed rate notes (3.775% to 5.650%) maturing 2028-2066.
- Largest tranches: $1.5B of 3.775% notes due 2028 and $1.5B of 4.750% notes due 2036.
- Longest maturity: $500M of 5.650% senior notes due 2066.
- Notes are unsecured, unsubordinated, and rank equally with existing unsecured debt.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1551152/000110465926023534/0001104659-26-023534-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1551152/000110465926023534/tm266774d4_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-26-023534

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer